ITHACA, a randomized multicenter phase 3 study of isatuximab in combination with lenalidomide and dexamethasone in high-risk smoldering multiple myeloma: safety run-in preliminary results

Autores: Ghobrial, I.; Rodríguez Otero, Paula; Koh, Y.; Martínez-López, J.; Parmar, G.; Prince, M.; Quach, H.; de la Rubia, J.; Hermansen, E.; Hungria, V.; Besisik, S. K.; Kim, J. S.; Leleu, X.; Peceliunas, V.; Schjesvold, F.; Dubin, F.; Devisme, C.; Lepine, L.; Mace, S.; Oprea, C.; Mateos, M. V.